The FDA alerted that Abiomed is removing Automated Impella Controllers after reports of serious injuries and deaths tied to purge cassette recognition issues. The notice points to a safety defect in the user control interface that monitors and alarms around catheter performance. Device recalls and field actions can disrupt hospital procurement and influence clinical protocols for mechanical circulatory support. For developers in cardiac devices, the incident also underlines the operational risk embedded in software and accessory interoperability. The removal is a near-term safety signal with direct relevance to catheter-based cardiology workflows.